The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control studyAstrid van Hylckama Vlieg, Frits R. Rosendaal, Jan P. Vandenbroucke et al.|BMJ|2009Cited by 664
Combined oral contraceptives: venous thrombosisTheo Stijnen, Frans M. Helmerhorst, Astrid van Hylckama Vlieg et al.|Cochrane Database of Systematic Reviews|2014Cited by 397
Oral Contraceptives and the Risk of Myocardial InfarctionBea C. Tanis, Frits R. Rosendaal, Frans M. Helmerhorst et al.|New England Journal of Medicine|2001Cited by 369
Female Hormones and ThrombosisFrits R. Rosendaal, Jan P. Vandenbroucke, Frans M. Helmerhorst|Arteriosclerosis Thrombosis and Vascular Biology|2002Cited by 267
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) StudyJeanet M. Kemmeren, Ale Algra, Yolanda van der Graaf et al.|Stroke|2002Cited by 225